Literature DB >> 2000014

The response to human rIL-1, rIL-2, and rTNF in the middle ear of guinea pigs.

A Catanzaro1, A Ryan, S Batcher, S I Wasserman.   

Abstract

Human recombinant interleukin 1 (rIL-1), interleukin 2 (rIL-2), or tumor necrosis factor (rTNF) were injected transtympanically into the middle ear of normal guinea pigs. Effusion volume and cellular content were determined after sacrifice and rapid dissection of the ear. By 24 hours, rIL-2 (100 U) had produced a cellular effusion (77% to 92% polymorphonuclear neutrophil leukocytes), which cleared by 72 hours. rTNF (10 U) yielded a cellular effusion (12% to 67% lymphocytes) at 24 hours, which cleared by 48 hours. rIL-1 (100 U) did not produce significant effusion when compared to control. rIL-2 and rTNF cause an inflammatory effusion in the middle ear. To the extent they are generated in the middle ear during otitis media, these cytokines have the potential to contribute to the pathogenesis of otitis media with effusion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2000014     DOI: 10.1288/00005537-199103000-00008

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  12 in total

1.  Effects of Allergina on the treatment of otitis media with effusions.

Authors:  Hyun-Ja Jeong; Seung-Heon Hong; Sung-Chul Kim; Eun-Jeong Park; Chul-Ho Jang; Kyung-Suk Kim; Hyung-Min Kim
Journal:  Inflammation       Date:  2002-04       Impact factor: 4.092

2.  The inflammasome adaptor ASC contributes to multiple innate immune processes in the resolution of otitis media.

Authors:  Arwa Kurabi; Jasmine Lee; Chelsea Wong; Kwang Pak; Hal M Hoffman; Allen F Ryan; Stephen I Wasserman
Journal:  Innate Immun       Date:  2014-03-20       Impact factor: 2.680

3.  Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model.

Authors:  K Sato; C L Liebeler; M K Quartey; C T Le; G S Giebink
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Pro-inflammatory interleukins in middle ear effusions from atopic and non-atopic children with chronic otitis media with effusion.

Authors:  Beata Zielnik-Jurkiewicz; Wanda Stankiewicz-Szymczak
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-16       Impact factor: 2.503

5.  Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by formalin-killed Haemophilus influenzae or its lipooligosaccharide htrB and rfaD mutants.

Authors:  H H Tong; Y Chen; M James; J Van Deusen; D B Welling; T F DeMaria
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

6.  CC chemokine ligand 3 overcomes the bacteriocidal and phagocytic defect of macrophages and hastens recovery from experimental otitis media in TNF-/- mice.

Authors:  Anke Leichtle; Michelle Hernandez; Joerg Ebmeyer; Kenshi Yamasaki; Yuping Lai; Katherine Radek; Yun-Hoon Choung; Sara Euteneuer; Kwang Pak; Richard Gallo; Stephen I Wasserman; Allen F Ryan
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

7.  Role of p38 mitogen-activated protein kinase in middle ear mucosa hyperplasia during bacterial otitis media.

Authors:  Sean D Palacios; Kwang Pak; Alexander Z Rivkin; Ayse G Kayali; Darrell Austen; Christoph Aletsee; Asa Melhus; Nicholas J G Webster; Allen F Ryan
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 8.  Innate Immunity: Orchestrating Inflammation and Resolution of Otitis Media.

Authors:  Arwa Kurabi; Kwang Pak; Allen F Ryan; Stephen I Wasserman
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

9.  TNFA deletion alters apoptosis as well as caspase 3 and 4 expression during otitis media.

Authors:  Joerg Ebmeyer; Anke Leichtle; Michelle Hernandez; Umay Ebmeyer; Jacob Husseman; Kwang Pak; Holger Sudhoff; David Broide; Stephen I Wasserman; Allen F Ryan
Journal:  BMC Immunol       Date:  2011-01-26       Impact factor: 3.615

Review 10.  Innate signaling in otitis media: pathogenesis and recovery.

Authors:  Anke Leichtle; Yuping Lai; Barbara Wollenberg; Stephen I Wasserman; Allen F Ryan
Journal:  Curr Allergy Asthma Rep       Date:  2011-02       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.